Erratum:
The original version of this article [1] unfortunately contained a mistake. The information in Table 1 was misrepresented.
Table 1.
Summary of iPSCs in this study
Clone name | Diagnosis | GFAP genotype | Sex | Age at onset | Age at sampling |
---|---|---|---|---|---|
HC1 | healthy | wild | female | - | 36 |
HC2 | healthy | wild | female | - | 67 |
HC3 | healthy | wild | male | - | 74 |
Alex1 | Alexander disease type I | R239C (c.729C>T) | male | 2 | 6 |
Alex2 | Alexander disease type I | E69K (c.205G>A) | female | 3 | 10 |
Alex3 | Alexander disease type II | L264P (c.791_792TG>CT) | female | 33 | 45 |
Abbreviations: GFAP Glial fibrillary acidic protein, HC Healthy control
Alex1 was generated from patient fibroblasts (GM16825) from Coriell Institute (Camden, NJ)
In Table 1 in the information related to Alex2 clone, E63K should read E69K and in the information related to Alex3 clone, R276L (c.827G>T) should read L264P (c.791_792TG>CT). Additionally, the second column header has been modified from “clinical character” to “Diagnosis”.
An updated version of Table 1 has been provided below.
Footnotes
The online version of the original article can be found under doi:10.1186/s40478-016-0337-0.
References
- 1.Kondo T, et al. Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes. Acta Neuropathol Commun. 2016;4:69. doi: 10.1186/s40478-016-0337-0. [DOI] [PMC free article] [PubMed]